| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: CRYO |
| Security Type |
Common Stock |
| Lead Underwriter |
WR Hambrecht & Co LLC |
| Days In Registration |
99 |
| Date Filed |
5-Apr-2005 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
CryoCor Inc, located in San Diego, California, manufactures and develops minimally invasive and disposable catheter systems for the treatment of cardiac arrhythmias called CryoCor Cardiac Cryoablation System that makes use of cold or cryoenergy to ablate and destroy targeted cardiac cells for patients with atrial flutter and atrial fibrillation. The company was founded in 2000. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
10.6M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
2.85M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
2.85M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
556.36K |
| File Amount |
$34.2M |
| File Price Range |
$14.00 - $10.00 |
| File Mid Price |
$12.00 |
Current Filing Information
(Amended 12-Jul-2005) |
|
US |
|
Shares Filed |
3.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
3.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$36.0M |
| · % Change from Original |
5.26 |
| File Price Range |
$13.00 - $11.00 |
| File Mid Price |
$12.00 |
|
